Editorial context: This is a hypothesis-led interpretation of one person's reported experience, not empirical validation of a mechanism. A single remission story cannot establish that a treatment caused remission or that the proposed genetic pathways are correct. The treatments mentioned—including prescription medicines and psychedelics—are not recommendations; readers should discuss treatment decisions with a qualified clinician.
This patient's remission story provides a remarkable empirical validation of the theoretical model derived from analyzing the DecodeME cohort data.
While the patient's journey relies on private and risky self-experimentation, the exact sequence of their interventions and observed effects aligns perfectly with the progressive neutralization of the pathophysiological triad and the repurposed drugs identified by our bioinformatic pipeline.
The DecodeME Biological Remission Framework
- Pole 1: Cellular & Oxygenation (HBOT, Pacing, Methylated B-Complex) — Biological function: prepares the energetic terrain and relieves cellular hypoxia.
- Pole 2: Neuro-Immune (SGB, LDN, Glymphatic Sleep) — Biological function: clears microglial inflammation and shuts off sympathicotonic stress.
- Pole 3: Synaptic & Calcium (Ketamine, rTMS, LSD — Final Reset) — Biological function: resets hyper-excitable cortical circuits and restores neuroplasticity.
Biological Details by Pole
Pole 1: Cellular Stress, Oxygenation & Metabolism (RPS27L, TRIM39, SLC25A17)
- What genetics reveals: The cell suffers a metabolic blockage, autophagy dysfunction, and a shift toward toxic peroxisomal over-activation (SLC25A17), leading to cellular hypoxia and energy exhaustion at the slightest exertion.
- What the patient executed: Radical Zero-Crash Pacing: stopping all workload imposed on cells incapable of producing ATP, preventing the triggering of the metabolic panic cascade. HBOT (Hyperbaric Oxygen Therapy): pressurized tissue hyper-oxygenation to bypass cellular hypoxia and reboot underlying mitochondrial function. Methylated B-Complex: bypassing the methylation blockage to supply indispensable cofactors for the Krebs cycle and neurotransmitter synthesis.
Pole 2: Neuro-inflammation & Microglial Activation (AIF1, TNFRSF6B)
- What genetics reveals: The presence of the AIF1 gene (Iba1) confirms chronic microgliosis—a low-grade inflammation of the central nervous system and brainstem that keeps the body in hyper-sympathicotonia ("fight-or-flight" mode).
- What the patient executed: SGB (Stellate Ganglion Block): targeted local anesthesia of the stellate ganglion to mechanically interrupt the sympathicotonic emergency signal. Deep Sleep & Glymphatic Drainage: SGB and ketamine restored deep sleep, the exact phase during which the glymphatic system flushes toxic metabolites and cytokines accumulated in the inflamed brain. LDN (Low Dose Naltrexone): direct dampening of microglial TLR4 receptors (AIF1), reducing the secretion of pro-inflammatory cytokines.
Pole 3: Synaptic Dysfunction & Calcium Channels (CAMK2B, BSN)
- What genetics reveals: Alteration of the Bassoon protein (BSN) and the CAMK2B subunit, disrupting synaptic vesicle release and calcium flux, driving sensory hypersensitivity and brain fog.
- What the patient executed: rTMS + Ketamine: direct desensitization of hyper-excitable cortical circuits and modulation of NMDA/glutamatergic receptors. Resonance Breathing: conscious recalibration of heart rate variability (HRV) to re-harmonize vagal control at the brainstem level. LSD (Serotonergic / 5-HT2A Compound): induction of massive neuroplasticity, allowing the reorganization of synaptic networks once the neuro-inflammatory terrain was calmed.
Why the sequence may matter in this model
The account proposes that the final dose of LSD triggered full remission—whereas it could have caused a severe relapse (PEM) earlier in the illness—because of the sequential preparation of the biological terrain:
- Step 1: Relieve Metabolic Load. Protocol: Radical Pacing + Methylated B-Complex + HBOT.
- Step 2: Quench Microgliosis & Sympathicotonic Stress. Protocol: SGB + LDN + Glymphatic Drainage Restoration (Sleep).
- Step 3: Reset Synaptic Transmission. Protocol: Resonance Breathing + rTMS/Ketamine + LSD (5-HT2A / Plasticity Reset).
Sequential mechanics proposed by the article
- Without Step 1 (HBOT/Pacing): synaptic stimulation (LSD/rTMS) applied to ATP-depleted cells immediately triggers toxic PEM and mitochondrial exhaustion.
- Without Step 2 (SGB/LDN/Drainage): synaptic stimulation in a brain where AIF1 (microglia) is activated escalates neuro-inflammation.
- Once the terrain is cleared and re-oxygenated: neuroplastic action on synaptic pathways (CAMK2B, BSN) lifts the functional blockage without encountering biological resistance.
Proposed links to drug-targeting hypotheses
This patient's empirical experimentation directly validates the logic of our LINCS L1000 / eQTL drug targeting:
- Sirolimus (Rapamycin) ↔ Pacing + HBOT + Glymphatic Sleep — Reactivation of cellular mitophagy and autophagy; restoration of protective RERE gene expression.
- Niclosamide ↔ Hypoxia & Oxidative Stress Control — Normalization of peroxisomal over-activation linked to SLC25A17 and extinction of the emergency STAT3 pathway.
- Auranofin ↔ LDN + SGB + Ketamine — Resetting blood immune cell metabolism (monocytes/NK) and lowering microgliosis markers (AIF1).
- Fluspirilene ↔ rTMS + LSD + Resonance Breathing — Calcium channel stabilization and synaptic modulation at BSN- and CAMK2B-dependent release zones.
The patient describes a very precise physical sensation during their LSD session: tension rising along the vagus nerve toward the brainstem, blocked at the frontal level, which suddenly "flipped polarity" to dissolve the brain fog.
Biologically, this phenomenon corresponds to two simultaneous releases in the proposed interpretation:
- Collapse of synaptic resistance: 5-HT2A receptors (activated by LSD) increase brain entropy and shatter pathological feedback loops maintained by a hyper-sympathicotonic autonomic nervous system.
- Lifting of calcium inhibition: in the presence of restored oxygen levels (HBOT) and lowered neuro-inflammation, BSN-dependent synaptic plasticity can restore normal cortico-subcortical communication.